Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune Woan, Frank Cichocki, Ramzey Abujarour et al.|Cell stem cell|2021Cited by 153
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myelomaFrank Cichocki, Jeffrey S. Miller|Nature Communications|2022Cited by 73
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphomaFrank Cichocki, Veronika Bachanová|Science Translational Medicine|2023Cited by 44
Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiencyJacob A. Myers, Jeffrey S. Miller, Rih‐Sheng Huang et al.|Blood|2025Cited by 4